WOBURN, Mass.--(BUSINESS WIRE)--Javelin Biotech (“Javelin”) today announces a three-year collaboration with Pfizer Inc. (NYSE: PFE) to design and build what could potentially be an industry-leading ...

In a study posted to the bioRxiv* preprint server, researchers studied the preclinical pharmacokinetics (PK) and in vitro absorption, distribution, metabolism, and elimination (ADME) properties of ...

In this panel webinar, we will discuss how artificial intelligence is advancing the prediction of molecular properties such as absorption, distribution, metabolism, and excretion (ADME). You will ...

Historically, the majority of compounds that failed in development did so because of poor pharmacokinetic (PK) properties. More recently, PK and ADME testing is being done earlier and in parallel with ...

In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. Understanding the ADME ...

Historically, it was not possible to detect ADME problems until the IND application preparation stage, which often led to “serious disruption of the development process, and often resulted in closure ...

Collaboration aims to create the first “organ-on-a-chip” system specifically designed for human PK predictions WOBURN, Mass.--(BUSINESS WIRE)-- Javelin Biotech (“Javelin”) today announces a three-year ...